Hospital-Acquired Infection Diagnostic and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Hospital-Acquired Infection (HAI) Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Infection (HAI) Diagnostic Overall Market Size
2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2028
2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
3.2 Top Global Hospital-Acquired Infection (HAI) Diagnostic Companies Ranked by Revenue
3.3 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Infection (HAI) Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Molecular Diagnostics
4.1.3 Blood Tests
4.1.4 Urinalysis
4.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2028
5.1.2 Urinary Tract Infections
5.1.3 Pneumonia
5.1.4 Surgical Site Infections
5.1.5 Bloodstream Infections
5.1.6 Other Hospital Infections
5.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2028
6.3.2 US Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.3.3 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.3.4 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2028
6.4.2 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4.3 France Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4.4 U.K. Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4.5 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4.6 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.4.8 Benelux Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2028
6.5.2 China Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.5.3 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.5.4 South Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.5.6 India Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2028
6.6.2 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.6.3 Argentina Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2028
6.7.2 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.7.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
6.7.5 UAE Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2017-2028
7 Players Profiles
7.1 bioM?rieux
7.1.1 bioM?rieux Corporate Summary
7.1.2 bioM?rieux Business Overview
7.1.3 bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.1.4 bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.1.5 bioM?rieux Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.2.4 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Abbott Laboratories Key News
7.3 Alere, Inc.
7.3.1 Alere, Inc. Corporate Summary
7.3.2 Alere, Inc. Business Overview
7.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.3.4 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Alere, Inc. Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.4.4 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Corporate Summary
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.5.4 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Siemens Healthcare Key News
7.6 Becton Dickenson
7.6.1 Becton Dickenson Corporate Summary
7.6.2 Becton Dickenson Business Overview
7.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.6.4 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.6.5 Becton Dickenson Key News
7.7 Cepheid Inc.
7.7.1 Cepheid Inc. Corporate Summary
7.7.2 Cepheid Inc. Business Overview
7.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.7.4 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Cepheid Inc. Key News
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.8.4 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.8.5 Thermo Fisher Scientific Key News
7.9 Seegene, Inc.
7.9.1 Seegene, Inc. Corporate Summary
7.9.2 Seegene, Inc. Business Overview
7.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.9.4 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.9.5 Seegene, Inc. Key News
7.10 Qiagen
7.10.1 Qiagen Corporate Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.10.4 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global Market (2017-2022)
7.10.5 Qiagen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hospital-Acquired Infection (HAI) Diagnostic Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Infection (HAI) Diagnostic Market Drivers in Global Market
Table 3. Hospital-Acquired Infection (HAI) Diagnostic Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Infection (HAI) Diagnostic in Global Market
Table 5. Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. bioM?rieux Corporate Summary
Table 31. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 32. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 35. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Alere, Inc. Corporate Summary
Table 37. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 38. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 41. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Siemens Healthcare Corporate Summary
Table 43. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 44. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. Becton Dickenson Corporate Summary
Table 46. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 47. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Cepheid Inc. Corporate Summary
Table 49. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 50. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 53. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Seegene, Inc. Corporate Summary
Table 55. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 56. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 59. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hospital-Acquired Infection (HAI) Diagnostic Segment by Type in 2021
Figure 2. Hospital-Acquired Infection (HAI) Diagnostic Segment by Application in 2021
Figure 3. Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2021
Figure 8. By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
